SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 12, 2026

MNKD

MANNKIND CORP
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $66K total
Actionable Insight • Neutral

The insider sales are too small to be informative. Focus on the upcoming PDUFA catalysts: Afrezza pediatric decision on May 29 (potential new patient population) and Furoscix ReadyFlow Autoinjector on July 26 (first IV-equivalent diuretic autoinjector). Q1 revenue growth of 15% and $134M cash position provide runway. Monitor for any insider buying ahead of these catalysts.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$3.28
T+0 close · May 11, 2026 · via day close
Latest settled
+18.60%
T+60 · $3.89
Vs SPY
+14.21%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 12 $3.28entry
  2. T+1 · 6mo ago −2.13%α −2.71% · $3.21
  3. T+5 · 6mo ago −9.76%α −9.16% · $2.96
  4. T+20 · 5mo ago +10.67%α +12.40% · $3.63
  5. T+60 · 3mo ago +18.60%α +14.21% · $3.89
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at MannKind Corp made open-market sales totaling $66K (0.007% of market cap) on May 12, 2026, one week after the company reported Q1 2026 revenue of $90.2M (+15% YoY) and highlighted upcoming PDUFA dates for Afrezza pediatric (May 29) and Furoscix ReadyFlow Autoinjector (July 26). The sales are trivial relative to the $1.0B market cap and are dwarfed by the $215K in tax-withholding share surrenders by the CEO and other executives on May 11, indicating the open-market sales are likely liquidity-driven rather than signaling a bearish view.

Key Financial Metrics

Direction
selling
Total Value
$66.0K
Insiders
2

Key Facts

  • Open-market sales: EVP Thomson sold $10K, Director Binder sold $56K, total $66K, or 0.007% of $1.0B market cap
  • Tax-withholding share surrenders on May 11: CEO Castagna ($123K), EVP Thomson ($44K), Director Binder ($20K), CPWO Tross ($28K), total $215K, non-cash events
  • Q1 2026 revenue $90.2M (+15% YoY); Afrezza $15.3M (+3%), Furoscix $15.5M (new), royalties $32.7M (+9%)
  • Two upcoming PDUFA dates: Afrezza pediatric (May 29, 2026) and Furoscix ReadyFlow Autoinjector (July 26, 2026)
  • Cash and investments $134M as of March 31, 2026; $36.3M convertible notes settled for $35.5M cash + 569K shares

Financial Impact

Open-market sales of $66K represent 0.007% of market cap, immaterial

insider_sales

Risk Factors

  • Afrezza pediatric PDUFA denial on May 29 would remove a key growth catalyst
  • Furoscix ReadyFlow Autoinjector PDUFA denial on July 26 would slow Furoscix growth trajectory
  • Selling, general and administrative expenses rose 116% YoY to $54.1M, pressuring margins
  • R&D expenses rose 56% to $17.2M, reflecting pipeline investment but near-term cash burn

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MNKD-1778718640742

Track record

17 reports on MNKD

Performance horizon

7 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +20.00% at T+60 after the May 27, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $4.23 Now $3.96 −6.38% settles Dec 9
  2. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  3. Nov 5, 202611d ago Press Release Bearish 5/10 Entry $3.90 Now $3.96 −1.54% settles Dec 7
  4. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $3.73 Now $3.96 +6.17% settles Dec 2
  5. Jul 29, 202615w ago Press Release Bullish 6/10 Entry $3.85 to $4.09 Now $3.96 +2.86% ▲ +6.23% +1.21% vs SPY
  6. Jul 24, 202616w ago 8-K Mixed 6/10 Entry $3.95 to $4.07 Now $3.96 +0.25% ▲ +3.04% −0.26% vs SPY
  7. Jul 17, 202617w ago Insider Cluster Neutral 3/10 Entry $3.98 to $3.90 Now $3.96 −0.50% ▼ −2.01% −6.13% vs SPY
  8. Jun 3, 202623w ago Press Release Neutral 5/10 Entry $3.36 to $4.52 Now $3.96 +17.86% ▲ +34.52% +35.52% vs SPY
  9. Jun 2, 202623w ago 8-K Bullish 7/10 Entry $3.43 to $4.05 Now $3.96 +15.45% ▲ +18.08% +19.64% vs SPY
  10. May 29, 202624w ago Press Release Bullish 8/10 Entry $3.77 to $4.24 Now $3.96 +5.04% ▲ +12.47% +14.26% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (11h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 13, 2026